A biotechnology company developing regenerative treatments for various disorders is licensing its lead therapy candidate for hearing loss to Astellas Pharma. . . . → Read More: Hearing Loss Cell Therapy Licensed in $625M Deal
|
|||||
|
|
A company designing treatments to restore the protective coating on nerve cells damaged by multiple sclerosis is collaborating with biotechnology enterprise Genentech. . . . → Read More: Genentech, Biotech Partner on Multiple Sclerosis 
First results from a clinical trial show a combination of immunotherapies extends survival among patients with melanoma, but shorter periods for other solid-tumor cancers. . . . → Read More: Trial Shows Immunotherapies Extend Life with Melanoma 
Researchers expanded the ability of the genetic editing technique known as Crispr to alter the make-up of RNA, adding more ways to treat diseases. . . . → Read More: Crispr Enhanced for RNA Editing 
A company developing diagnostics for cognitive disorders from changes in speech patterns is partnering on vocal biomarkers to track progression of a form of dementia. . . . → Read More: Voice Indicators to Monitor Dementia Progression 
A biotechnology enterprise developing personalized treatments for cancer and infectious diseases is raising $325 million in its second venture funding round. . . . → Read More: Immunotherapy Biotech Gains $325M in Venture Funds
A company begun last year to create cancer therapies from banked, off-the-shelf stem cells is raising $250 million in its first round of venture financing. . . . → Read More: Stem Cell Start-Up Raises $250M in Venture Funds  One comment - (Comments are closed)  Finance, Joint ventures/collaborations  biomedical, biotechnology, cancer, entrepreneurs, equity, genomics, investment, Japan, licensing, manufacturing, pharmaceuticals, stem cells, university, venture capital 
A clinical trial is getting underway testing a treatment for stroke delivered to patients by emergency medical technicians on the way to the hospital. . . . → Read More: Trial Testing Paramedic-Delivered Stroke Drug Comments are closed New products biomedical, biotechnology, clinical trials, health care, life sciences, pharmaceuticals, university 
Researchers in Germany are developing techniques with artificial DNA and hydrogel designed to control the sequence of drugs delivered into the body. . . . → Read More: Artificial DNA Designed to Control Drug Delivery Comments are closed New products biomedical, biotechnology, chemistry, engineering, Europe, genomics, life sciences, materials science, nanotechnology, pharmaceuticals, physical sciences, university 
Two biotechnology enterprises in the U.S. issued their initial public stock offerings yesterday, with each company raising at least $300 million in their transactions. . . . → Read More: Two Biotechs Each Issue $300M+ IPOs Comments are closed Finance biomedical, biotechnology, clinical trials, entrepreneurs, equity, genomics, investment, IPO, life sciences, mathematics, medical device, pharmaceuticals, physical sciences |
||||
|
Copyright © 2019 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||